| Structure determination of a potent, selective antibody inhibitor of human MMP9 (GS-5745 bound to M… | |
Heteromer
| 40-443 | 100.0 | 2×ZN; 2×CA; 1×NCO; |
|
| Crystal structure of mutant MMP-9 catalytic domain in complex with a twin inhibitor. | | homo-2-mer | 110-444 | 100 | 4×ZN; 6×CA; 1×L29; |
|
| Crystal structure of an MMP twin carboxylate based inhibitor LC20 in complex with the MMP-9 catalyt… | | homo-2-mer | 110-444 | 100 | 4×ZN; 6×CA; 1×0ZD; 5×GOL; 6×PGO; 7×PEG; 1×MLT; |
|
| MMP9 active site mutant-inhibitor complex | | homo-2-mer | 110-443 | 100 | 8×CA; 2×STN; 2×BUM; 4×ZN; |
|
| Dimeric form of the haemopexin domain of MMP9 | | homo-2-mer | 513-707 | 98.97 | 4×SO4; |
|
| Crystal structure of human matrix metalloproteinase MMP9 (gelatinase B). | | monomer | 29-444 | 99.75 | 2×ZN; 3×CA; |
|
| Crystal structure of human proMMP-9 catalytic domain in complex with inhibitor | | monomer | 38-444 | 100 | 2×ZN; 3×CA; 1×VP6; 1×2HP; |
|
| Crystal structure of human proMMP-9 catalytic domain in complex with inhibitor | | monomer | 38-444 | 100.0 | 2×ZN; 3×CA; 1×VOC; |
|
| Crystal structure of human proMMP-9 catalytic domain in complex with inhibitor | | monomer | 38-444 | 100.0 | 2×ZN; 3×CA; 1×VOO; |
|
| Crystal structure of human proMMP-9 catalytic domain in complex with inhibitor | | monomer | 39-444 | 100.0 | 2×ZN; 3×CA; 1×VOZ; |
|
| proMMP-9desFnII complexed to JNJ0966 INHIBITOR | | monomer | 40-443 | 100.0 | 2×ZN; 3×CA; 1×SO4; |
|
| proMMP-9desFnII | | monomer | 41-443 | 100 | 2×ZN; 3×CA; 2×SO4; |
|
| Structure determination of a potent, selective antibody inhibitor of human MMP9 (apo MMP9) | | monomer | 41-443 | 100.0 | 2×ZN; 3×CA; |
|
| Crystal structure of an inactive mutant of MMP-9 catalytic domain in complex with a fluorogenic syn… | | monomer | 107-444 | 100 | 1×AZI; 2×ZN; 1×CA; 2×SR; 1×PGO; 2×EDO; 1×PEG; 1×GOL; |
|
| Crystal structure of an MMP broad spectrum hydroxamate based inhibitor CC27 in complex with the MMP… | | monomer | 107-444 | 100 | 2×ZN; 3×CA; 1×10B; 6×GOL; 1×PGO; |
|
| Crystal structure MMP-9 complexes with a constrained hydroxamate based inhibitor LT4 | | monomer | 107-444 | 100 | 2×ZN; 3×CA; 1×LTQ; 2×EDO; 1×PGO; |
|
| Crystal structure of an inactive mutant of MMP-9 catalytic domain in complex with a fluorogenic syn… | | monomer | 107-444 | 100 | 1×AZI; 2×ZN; 2×CA; 1×SR; 5×EDO; 1×GOL; 1×PGO; |
|
| Crystal structure of an MMP twin inhibitor complexing two MMP-9 catalytic domains | | monomer | 107-444 | 100 | 2×ZN; 2×CA; 6×PEG; 3×ACT; 2×BCN; |
|
| Crystal structure of mutant MMP-9 catalytic domain in complex with a twin inhibitor. | | monomer | 110-444 | 100 | 2×ZN; 4×CA; 1×0XX; |
|
| MMP-9 active site mutant with barbiturate inhibitor | | monomer | 110-443 | 100 | 2×ZN; 5×CA; 3×CL; 1×4MR; |
|
| MMP-9 active site mutant with phosphinate inhibitor | | monomer | 110-443 | 100 | 2×ZN; 5×CA; 3×CL; 1×5MR; |
|
| MMP-9 active site mutant with iodine-labeled carboxylate inhibitor | | monomer | 110-443 | 100 | 2×ZN; 4×CA; 4×CL; 1×6MR; |
|
| MMP-9 active site mutant with trifluoromethyl hydroxamate inhibitor | | monomer | 110-443 | 100 | 2×ZN; 4×CA; 3×CL; 1×7MR; |
|
| MMP9-inhibitor complex | | monomer | 110-443 | 100 | 5×CA; 1×NFH; 2×ZN; |
|
| Crystal structure of MMP9 in complex with inhibitor BE4. | | monomer | 112-444 | 100 | 2×ZN; 3×CA; 1×B9Z; 1×PZE; |
|
| Crystal structure of a hydroxamate based inhibitor EN140 in complex with the MMP-9 catalytic domain | | monomer | 112-444 | 100 | 1×E40; 2×ZN; 3×CA; 1×EDO; 2×PGO; 2×PEG; |
|
| Crystal structure of a hydroxamate based inhibitor ARP101 (EN73) in complex with the MMP-9 catalyti… | | monomer | 113-444 | 100 | 1×N73; 2×ZN; 3×CA; 2×DMS; 4×EDO; 1×GOL; 2×PGO; 1×BUD; |
|
| Crystal structure of the catalytic domain of MMP-9 in complex with a selective sugar-conjugated ary… | | monomer | 113-444 | 100 | 2×ZN; 3×CA; 1×H27; 1×EDO; 1×DMS; 1×GOL; |
|
| MMP-9 active site mutant with difluoro butanoic acid inhibitor | | monomer | 113-443 | 100 | 2×ZN; 3×CA; 2×CL; 1×8MR; |
|